</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3003.90.01.20/Remdesivir Bulk API Mixture/Japan

Remdesivir Bulk API Mixture from Japan

Remdesivir bulk API mixture is an antiviral for COVID-19 and Ebola treatment, mixed for IV formulation production. Excluded from retail forms, it is classified in HTS 3003.90.0120 as a bulk antiviral.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.05.860%Universal product exemption (U.S. note 52(b))
Calculate with your customs valueVerify classification with AI

Import Tips

• Monitor FDA import alerts for high-risk antivirals like Remdesivir

• Include viral efficacy studies in documentation; pitfall is missing potency assays

• Ship under controlled temperature with data loggers